BioSpace News Archive

SQI Diagnostics Inc., a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, is proud to announce the launch of its newly redesigned website at https://www.sqidiagnostics.com.

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it plans to release its fourth quarter 2020 financial results after the market closes on Thursday, March 4, 2021. In conjunction with such release, DermTech plans to host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time

Alnylam to Webcast Presentation at 10 th Annual SVB Leerink Global Healthcare Conference

Enanta Pharmaceuticals to Present at SVB Leerink 10 th Annual Global Healthcare Conference

Mirati Therapeutics, Inc., a late-stage targeted oncology company, will participate in two upcoming healthcare conferences.

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the 10th Annual SVB Leerink Global Healthcare Conference as follows: Date: Wednesday, February 24, 2021 Time: 9:20 a.m. Eastern Time Webcast: https://wsw.com/webcast/svbleerink47/osmt/269

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today the commencement of a proposed underwritten public offering of its shares of common stock. All the shares will be offered by the Company. The Company also expects to grant the underwriters a 30-day option to purchase additional shares of common stock in an amount of up to 15% of the nu

Thermo Scientific Vanquish Online 2D-Liquid Chromatography (LC) Systems offer a robust and flexible platform for pharmaceutical/biopharmaceutical R&D, food safety, environmental testing, omics and polymer analysis scientists to characterize complex samples in-depth with the highest confidence

Researchers at the University of Maryland School of Medicine (UMSOM) and their colleagues published a new analysis today in the journal Nature from genetic sequencing data of more than 53,000 individuals, primarily from minority populations

Q4 revenue growth, reduced operating expenses, and successful closing of public offering in January position Company with capital resources through end of 2022 Company to host a year-end conference call on March 18, 2021 at 5:00 PM ET